| Nita Chatterjee, MD | |
|
415 Riverside Dr., Thompson Med Ctr, North Grosvenordale, CT 06255 | |
| (860) 923-1181 | |
| (860) 923-1822 |
| Full Name | Nita Chatterjee |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 49 Years |
| Location | 415 Riverside Dr., North Grosvenordale, Connecticut |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164469854 | NPI | - | NPPES |
| 001364017 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 154296 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Day Kimball Hospital | Putnam, CT | Hospital |
| Westview Nursing Care & Rehab | Dayville, CT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thompson Medical Llc | 2062739535 | 2 |
News Archive
Varian Medical Systems today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a Calypso® soft tissue Beacon® transponder that can help enhance the precision of radiotherapy and radiosurgery treatments for cancer.
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a 1-hour high-dose intravenous (IV) infusion.
Having good friends can save your life, as a study based on data from the Women's Health Initiative demonstrates how strong social support may reduce the risk of death from cardiovascular disease in postmenopausal women.
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week 2020.
› Verified 2 days ago
| Entity Name | Thompson Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750783619 PECOS PAC ID: 2062739535 Enrollment ID: O20150320000956 |
News Archive
Varian Medical Systems today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a Calypso® soft tissue Beacon® transponder that can help enhance the precision of radiotherapy and radiosurgery treatments for cancer.
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a 1-hour high-dose intravenous (IV) infusion.
Having good friends can save your life, as a study based on data from the Women's Health Initiative demonstrates how strong social support may reduce the risk of death from cardiovascular disease in postmenopausal women.
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week 2020.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nita Chatterjee, MD 415 Riverside Dr, North Grosvenordale, CT 06255-2165 Ph: (860) 923-1181 | Nita Chatterjee, MD 415 Riverside Dr., Thompson Med Ctr, North Grosvenordale, CT 06255 Ph: (860) 923-1181 |
News Archive
Varian Medical Systems today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a Calypso® soft tissue Beacon® transponder that can help enhance the precision of radiotherapy and radiosurgery treatments for cancer.
Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company's lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a 1-hour high-dose intravenous (IV) infusion.
Having good friends can save your life, as a study based on data from the Women's Health Initiative demonstrates how strong social support may reduce the risk of death from cardiovascular disease in postmenopausal women.
Transferring fecal matter from the digestive systems of healthy donors to extremely ill patients who had previously been infected with drug-resistant bacteria resulted in shorter hospital stays, fewer bloodstream infections and infections that were easier to treat, according to research that was selected for presentation at Digestive Disease Week 2020.
› Verified 2 days ago